Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Phase 2/3 results show that the bivalent second booster that targets both the original virus and the Omicron variant was superior to the standard booster a month after vaccination across age groups.
The new boosters are suited to two COVID-19 strains of the Omicron virus variant that represents the vast majority of infections, according to the FDA.